Ondine and Mid Yorks win national healthcare partnership award.

Ondine Biomedical and Mid Yorkshire Teaching NHS Trust won the Excellence in Healthcare Partnership Award for a Steriwave nasal photodisinfection programme that reported a 71% reduction in hip surgery infections and no knee surgery SSIs during the evaluation period.

Ondine Biomedical Inc. and Mid Yorkshire Teaching NHS Trust have been awarded the Excellence in Healthcare Partnership Award for a local project using Steriwave nasal photodisinfection to reduce surgical site infections. The article mentions Ondine Biomedical Inc., a Canadian life sciences company that develops light-activated antimicrobial therapies. Mid Yorkshire introduced Steriwave into orthopaedic surgery pathways in 2024 for patients undergoing hip and knee replacement surgery. The pilot evaluation reported a 71% reduction in post-surgical infections in hip surgery and no SSIs observed in knee surgery during the evaluation period. Key details: - The award was in the Partnership Working to Address National Healthcare Priorities (Local Projects) category and was announced at the 2026 Excellence in Healthcare Partnership Awards ceremony. - Steriwave nasal photodisinfection was implemented at Mid Yorks in 2024 within orthopaedic pathways for hip and knee replacement patients. - The reported evaluation associated the intervention with a 71% reduction in post-surgical infections in hip surgery and no observed SSIs in knee surgery during the evaluation period. - The article states Steriwave is being used or evaluated by several major hospitals across England and in intensive care following cardiac surgery. - The article notes Steriwave is CE-marked in Europe and approved for nasal decolonisation in several countries, and that Ondine and Mid Yorks are shortlisted for the HSJ Partnership Awards with winners to be announced on 19 March 2026. Summary: The award recognises a partnership reported to have reduced surgical site infections and lowered avoidable complications and associated hospital resource use. The collaboration has prompted wider evaluation and use of the technology across several English hospitals. Ondine and Mid Yorks remain shortlisted for an additional HSJ award, with winners to be announced on 19 March 2026.